congress
presentations
Clinical Trials on Alzheimer's Disease conference (CTAD)
Boston, Massachusetts
24 - 27 October 2023
AXS-05 | Alzheimer’s Disease Agitation | Poster #LP093
Efficacy and Safety Of AXS-05 in Alzheimer’s Disease Agitation: Results From ACCORD, a Phase 3, Double-Blind, Placebo-Controlled, Relapse Prevention Study
view/download